– UK, London – The Board of The Biotech Growth Trust PLC (LSE:BIOG), is pleased to announce the appointment of Mr Geoffrey C. Hsu as a non-executive Director of the Company, with effect from 16 May 2018.
Mr Hsu is a General Partner at OrbiMed Capital LLC, the Company’s Portfolio Manager. He joined OrbiMed in 2002 as a biotechnology analyst. Prior to joining OrbiMed, he worked as an analyst in the healthcare investment banking group at Lehman Brothers. Mr. Hsu received his A.B. degree summa cum laude from Harvard University and holds an M.B.A. from Harvard Business School. Prior to business school, he spent two years studying medicine at Harvard Medical School.
Mr Hsu does not currently hold any of the Company’s ordinary shares.
For more information : http://www.biotechgt.com
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.